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Many infections are caused by pathogens that are
similar, but not identical, to previously encountered
viruses, bacteria, or vaccines. In such re-infections,
pathogens introduce known antigens, which are
recognized by memory T cells and new antigens
that activate naive T cells. How preexisting memory
T cells impact the repertoire of T cells responding
to new antigens is still largely unknown. We demon-
strate that even a minimum epitope overlap between
infections strongly increases the activation threshold
and narrows the diversity of T cells recruited in
response to new antigens. Thus, minimal cross-reac-
tivity between infections can significantly impact the
outcome of a subsequent immune response. Inter-
estingly, we found that non-transferrable memory
T cells are most effective in raising the activation
threshold. Our findings have implications for
designing vaccines and suggest that vaccines meant
to target low-affinity T cells are less effective when
they contain a strong CD8 T cell epitope that has pre-
viously been encountered.
INTRODUCTION
Throughout life, we are constantly challenged by pathogens, and
re-exposure to previously encountered viruses or bacteria hap-
pens frequently. Homologous re-infections are often effectively
controlled by neutralizing antibodies, but pathogens that ex-
press altered serological epitopes (heterosubtypic re-infection)
can bypass antibody-mediated immunity and cause a second-Cell
This is an open access article under the CC BY-Nary infection (Corti and Lanzavecchia, 2013). The immunological
conditions found in such infections differ in many respects from
primary infections. Right at the beginning of such a re-infection,
the T cell repertoire may already contain large numbers of path-
ogen-specific T cells, and some of these can immediately exert
effector function (Zhang and Bevan, 2011). Moreover, preexist-
ing pathogen-specific but insufficiently neutralizing antibodies
could strongly alter infection and replication kinetics (Beura
et al., 2016) of a pathogen, and this may significantly alter tissue
tropism (Rothman, 2011). Such changes in host immunity are not
limited to the adaptive immune response. It has been shown that
cells of the innate arm of the immune system can respond more
vigorously (Sun et al., 2009), and memory CD8 T cells can even
contribute to controlling pathogen load in the early phase of
infection in a non-cognate, innate-like fashion (Chu et al.,
2013). Thus, pathogen spreading, antigen presentation, T cell
activation kinetics, and levels of inflammation and tissue
destruction can significantly vary between primary and second-
ary infections.
A particular feature of heterosubtypic re-infections is that
many antigens are shared in the primary and secondary infec-
tion, but the second pathogen expresses epitopes, which are
new to the immune system. Such a situation of preexisting partial
immunity to a pathogen can also occur in a primary infection
when a pathogen happens to share an epitope with a previously
encountered unrelated pathogen—a phenomenon known as
heterologous immunity (Welsh et al., 2010, Che et al., 2015).
Though highly relevant for understanding immunity in humans,
interferences between past and present infections (or vaccina-
tions) are rarely investigated under well-defined conditions.
Thus, we still have very limited insight into how existing immunity
impacts T cell activation, expansion, and conversion into effector
and memory T cells. Similarly, pre-existing partial immunity can
significantly alter the outcome of vaccination (Frahm et al., 2012).Reports 17, 627–635, October 11, 2016 ª 2016 The Author(s). 627
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
It is also particularly important to consider that pre-existing im-
munity does not inevitably result in better immune protection.
Instead, certain re-infections are known to be accompanied by
enhanced pathology, as occurs when a Dengue-virus-immune
individual is exposed to a different virus serovar (Rothman,
2011). Similarly, certain vaccination trials are suspected to
have augmented the severity of subsequent infections (Blanco
et al., 2010, Moore et al., 2008). The mechanisms underlying
such disease enhancement are not clearly resolved, and it is
not known how frequently this may occur. All of these points
strongly underline the need to investigate immune responses in
immune or partially immune individuals.
Here, we utilize well-controlled experimental systems to
dissect and characterize how different levels of pre-existing im-
munity influence T cell responses. We observed that T cell
activation thresholds differ substantially between primary and
secondary infections. We report that only the highest-affinity li-
gands induce T cell expansion in heterosubtypic re-infections,
whereas minor reductions in the levels of TCR stimulation fail
to induce T cell expansion. Importantly, we show that neither a
shortened inflammatory response nor a globally altered antigen
presentation pattern are responsible for raising the threshold.
Instead, we found that even a single shared epitope recognized
by previously formed memory CD8+ T cells is sufficient to in-
crease the T cell activation threshold of naive T cells. We noted
that this elevated threshold is mediated by a non-transferrable
endogenous memory T cell population. Together our data pro-
vide relevant insights into T cell differentiation mechanisms in
secondary heterosubtypic infections and for the design of vac-
cines that are given multiple times.
RESULTS
Only Very High-Affinity T Cells Expand in Secondary
Infections
We previously reported that low-affinity T cells differentiate into
effector and memory cells in primary infections (Zehn et al.,
2009). We established this using recombinant Listeria strains,
which express full-length Ovalbumin [Ova] that contains either
the original high-affinity, H-2Kb-restricted OT-1 ligand SIINFEKL
(Ova357–364) or different altered peptide ligands (APLs) A2 >
Y3 > Q4 > T4 APL (listed in decreasing OT-1 stimulatory po-
tency). We then became interested in addressing the stimulation
requirements in secondary heterosubtypic re-infections. To do
so, we infected naive or wild-type Listeria (Lm-WT)-experienced
mice with Lm-Ova- or APL-expressing Listeria (see Figure 1A).
With this experimental setup, we mimic a frequently occurring
situation where an individual is immune to some but not all anti-
gens in a secondary infection. We observed that the high-affinity
OT-1 ligand N4 induces similar expansion in mice with or without
a previous Lm-WT immunization. In contrast, OT-1 expansion in
response to Listeria expressing the slightly weaker SAINFEKL
(A2) or SIYNFEKL (Y3) APL was decreased in Lm-WT immune
mice (Figure 1B) and significantly impaired in response to Q4
or T4. Similar exclusions of low-affinity T cells were observed
when we transferred OT-1 T cells before the primary Lm-WT
infection (Figure S1A) and when memory OT-1 T cells were
used instead of naive OT-1 T cells (Figure S1B). Notably, both628 Cell Reports 17, 627–635, October 11, 2016N4 and T4 induce similar carboxyfluorescein succinimidyl ester
(CFSE) dilution in primary infections, but only N4 induces robust
proliferation in immune mice (Figure 1C). Some OT-1 T cells pro-
liferate in response to T4 in Listeria-immunemice, but this did not
increase total OT-1 T cells (data not shown). We therefore
conclude that low-affinity stimulation leads to an abortive T cell
response in heterosubtypic re-infections.
To illustrate the relevance of our observation, we transferred
low-affinity H-2Kb/Ova-specific OT-3 TCR transgenic T cells
(Enouz et al., 2012) into naive or Lm-WT immune Rip-mOva
mice. The Lm-WT immune mice were then infected with the
same challenge as in Figure 1A, whereas the naive Rip-mOva
mice received a priming dose. Using this setup, only naive
mice showed diabetic blood glucose levels above 300 mg/dL
(Figure 1D).
T Cell Activation Threshold in Primary Infections
Next, we wanted to define the difference in the affinity range of
T cells responding in primary versus heterosubtypic infections.
We previously showed that the low-affinity V4 ligand activates
OT-1 T cells (Zehn et al., 2009), even though it has a 1,000-
fold lower EC50 than the N4 ligand (Figure 2A). Interestingly, the
D4 APL has an EC50 value that is 10,000-fold below N4. To test
the OT-1 T cell response to this very low-affinity ligand, we gener-
ated a recombinant Lm-D4 strain. We confirmed that the Lm-D4
strain is infectious and comparable to Lm-N4 (Figure S2A).
Unexpectedly, even Lm-D4 induced rapid initial OT-1proliferation
(Figure 2B). D4 activated OT-1 T cells secrete TNF and IFNg (Fig-
ure 2C) and produce granzyme B (Figure 2D), and they differen-
tiate into memory T cells that can undergo secondary expansion
(Figure 2E). We illustrated this by transferring OT-1 cells into
mice that were either infected with Lm-D4 or with Lm-WT. Four
weeks later,we challenged themicewith Vesicular stomatits virus
expressing Ova (VSV-Ova). We noticed higher numbers of OT-1
cells in mice primed by D4 in comparison to Lm-WT-primed
mice that donot stimulateOT-1Tcells (Figure2E). Thus, the ability
ofD4 to activateOT-1T cells indicated that the signal 1 (TCRstim-
ulation) activation requirement in primary infections is very low.
In contrast, the difference between the normal N4 and the A2
or Y3 APL is rather small (Figure 2A). Nonetheless, this level
already strongly impairs T cell expansion in secondary or
cross-reactive infections. We therefore conclude that there is a
substantial stimulation threshold difference between primary
and secondary infections. To further illustrate the significance
of this difference, we marked the known boundaries for ligands
which induce positive and negative selection of OT-1 T cells in
Figure 2A, whereby T4 is the threshold ligand between positive
and negative selection (Figure 2A) (Daniels et al., 2006).
G4 is known to induce positive selection in fetal thymic organ
cultures (Yachi et al., 2006). Given that D4 with a potency much
below G4 supports effector T cell differentiation, we wondered
whether even the presumed endogenous positive selecting li-
gands for OT-1, ISFKFDHL from the F-Actin capping protein
(cpa1) and RTYTYEKL from b-catenin (Hogquist et al., 1997;
Santori et al., 2002) would drive OT-1 expansion when ex-
pressed by Listeria, but this was not the case (Figure 2F). We
confirmed that the lack of an OT-1 response is not due to a
lack of bacterial replication and that an Lm-bcat infection is, in
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Figure 1. Only High-Affinity T Cells Expand
in Listeria-Immune Mice
(A) Schematic illustration of the Experimental Pro-
cedures. Naive controls and C57BL/6 mice in-
fected with wild-type Listeria (Lm-WT) received 104
naive OT-1 4 weeks later and the indicated Listeria
strains.
(B) Frequency of OT-1 T cells among peripheral
blood CD8+ T cells 6 days after infection. Numbers
indicate the ratio of OT-1 T cells in naive and Lm-
WT immune hosts.
(C) Naive or Lm-WT immune mice grafted with
2.5 3 105 CFSE-labeled OT-1 cells and infected
with Lm-N4 or Lm-T4. CFSE dilution among splenic
OT-1 (filled histogram) was measured 78 hr later.
Dashed lines are unlabeled host CD8+ T cells. Data
are representative of three (B) or two (C) indepen-
dent experiments with three to five mice per group.
(D) Naive or Lm-WT infected Rip-mOva mice were
4 weeks later engrafted with low-affinity H-2Kb/
Ova-specific OT-3 TCR transgenic T cells and then
infected with Lm-N4. Blood glucose levels were
determined 8 days later. Statistical analysis are
unpaired Student’s t tests with **p < 0.01 and
****p < 0.0001.this respect, comparable to an Lm-N4 infection (Figure S2A). E1
Ova (EIINFEKL) is the only known APL that supports OT-1-pos-
itive selection in vivo (Stefanski et al., 2001). The lack of a periph-
eral response to E1 (Figure 2F) suggests that it more closely
resembles the quality of ligands (cpa1 and b-catenin) that are
thought to naturally support positive selection.
A Minimum Epitope Overlap Augments the CD8+ T Cell
Activation Threshold
Given the activation threshold differences in primary versus het-
erosubtypic infections, we sought to define the responsible
mechanism. Depletion of CD4+ T cells and NK cells from Lm-
WT primed mice did not restore low-affinity T cell activation
(data not shown). Taking a possible role of Listeria-specificCell Rmemory CD8+ T cells into consideration,
we set up a system that allowed us to con-
trol the size of the antigen-specific mem-
ory population by sharing only one CD8+
T cell epitope between two consecutive
infections. We constructed Listeria strains
that express N4 or T4 plus the Lympho-
cytic choriomeningitis virus (LCMV)-
derived gp33-41 epitope. We found that
Lm-gp33-N4 and Lm-gp33-T4 have
similar in vivo growth rates (Figure S2A)
and induce similarly sized populations of
endogenous gp33-specific T cells (data
not shown and Figures S2B and S2C).
When OT-1 T cells are primed by these
Listeria strains in naive or LCMV immune
hosts (Figure 3A), we observed a 2-fold
reduction in OT-1 expansion to N4 and
an essentially non-detectable responseto T4 in LCMV immune mice (Figure 3B). This indicates
that pre-existing antigen-specific memory CD8+ T cells effec-
tively raise the T cell activation threshold and that only one
epitope (or two if one also considers the H-2Kb-restricted gp34
epitope) (Hudrisier et al., 1997) is sufficient to alter the T cell
response.
Changes in Inflammation or Duration of Antigen
Presentation Are Not Responsible for Raising the
Activation Threshold
We considered that rapid Listeria clearance in immune
hosts might shorten the duration of antigen-presentation
and lower the magnitude of concomitant inflammation (Zehn
et al., 2014; Prlic et al., 2006). To address this point, weeports 17, 627–635, October 11, 2016 629
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B Figure 2. Even Extremely Low-Affinity Stimu-
lation InducesNormal Activation andMemory
Generation
(A) Dose response curves graphing peptide con-
centration against the fraction of maximum numbers
of IFNg producing T cells were obtained by briefly
stimulating an OT-1 T cell line in vitro with the indi-
cated peptides. Note that only a fraction of the OT-1
T cells produced IFNg after very low-affinity ligand
stimulation. Data were therefore normalized to bet-
ter compare the EC50.
(B) C57BL/6 mice transferred with 2 3 105 CFSE-
labeled OT-1 cells and infected the indicated Listeria
strains were analyzed for splenic CFSE dilution at
76 hr post infection.
(C and D) Naive mice received 105 OT-1 T cells
and an Lm-D4 or Lm-N4 infection. Splenocytes
were 4.5 days later and briefly re-stimulated with
SIINFEKL peptide and stained intracellularly for
IFNg, TNF (C), and GrzB (D). (C) shows representa-
tive OT-1 and (D) CD8+ gated flow cytometry plots.
(E) Naive mice received 2 3 104 OT-1 and the indi-
cated Listeria strains and OT-1 frequency among
peripheral blood CD8+ T cells was determined
28 days later. Themicewere then infected with VSV-
N4, and the OT-1 frequency was measured 4 days
later in the blood.
(F) CFSE+ OT-1-containing mice were infected with
Lm-N4, Lm-Cpa1, Lm-bcat, or Lm-E1 and analyzed
as described in (B).
The data are representative for four (A) or three in-
dependent experiments with three to five mice per
group (B, C, and D) or two experiments with two to
five mice per group (E and F). Statistical analysis are
unpaired Student’s t tests, ****p < 0.0001.transferred CFSE-labeled OT-1 T cells into naive or Lm-WT-
primed mice and challenged them with Lm-N4. We observed
similar CFSE dilution in naive and immune hosts excluding major
differences in antigen presentation kinetics in the two hosts (Fig-
ures 3C and 3D). Also anti-CD40-mediated DC maturation or
administration of recombinant IFNa to increase inflammation
left the T4 response unchanged (data not shown). Next, we es-
tablished comparable levels of Listeria induced inflammation
and tissue destruction in LCMV immune and naivemice by co-in-
jecting Lm-WT and Lm-gp33-T4 into LCMV immune mice. Here,
only Lm-gp33-T4 are recognized bymemory T cells, whereas the
Lm-WT infection propagates normally. This resulted in similar
absolute Listeria titers in LCMV immune and naive mice, but
the response to T4 remained unchanged in immune mice (Fig-
ure 3E). To control for an impact of the different Listeria challenge
doses in naive or immune mice (Figures 1, 3A, and 3B), we used
ActA-deficient Listeria. These strains cannot spread from cell to
cell and are rapidly cleared by the host, allowing C57BL/6 mice
to be challenged with a high Listeria dose. This creates a setup
in which antigen levels are primarily dependent on the amount
of the initial bacterial challenge dose, but not the in vivo expan-
sion, of injected bacteria. We observed a lack of low-affinity
T cell expansion in immune mice challenged with ActA-deficient
Lm (Figure 3G). This excludes a principle shortage in antigen pre-
sentation and a lower inflammatory response as causes of the
observed effect.630 Cell Reports 17, 627–635, October 11, 2016Transferred T Cells Are Less Effective in Raising the
Activation Threshold than Endogenous T Cells
To determine whether the presence of memory T cells is sufficient
to raise the activation threshold, we transferred gp33-specific
memory T cells into new C57BL/6 hosts along with CD45.1/2
congenic OT-1 T cells. Contrasting our prior observation, the
transferred memory P14 T cells reduced, but did not completely
suppress, the OT-1 response to Lm-gp33-T4. In an Lm-gp33-N4
infection, the same P14 dose caused only a minor impact on the
OT-1 response (Figure 4A). Similar outcomes were observed
when P14 memory T cells were transferred 28 or 80 days after
the LCMV infection (Figure S3A). We considered the possibility
that the number of transferred P14 T cells was too low to suppress
the T4 response effectively and therefore increased the number of
transferred P14 to 106 cells. Again, the T4 response was incom-
pletely blocked, but surprisingly, this P14 dose already caused a
strongdecline in thehigh-affinityOT-1 response (Figure4B). These
data suggest that transferring memory T cells is not sufficient to
recapitulate the selective and complete exclusion of low-affinity
T cells, as observed when endogenous memory T cells respond
to a pathogen expressing a shared antigen (Figure 1).
To exclude a sole OT-1-dependent phenomenon, we reversed
the strategy and used the recently described gp33C6 low-affinity
APL for P14 T cells (Utzschneider et al., 2016). We transferred
OT-1 memory and naive P14 T cells into naive B6 mice and
infected them with Listeria expressing Ova and wild-type
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Figure 3. Memory CD8+ T Cells Raise the
Activation Threshold in Secondary Infec-
tions Independently of the Inflammatory
Milieu
(A and B) Control (–) or LCMV-immune mice
received 4 weeks after the infection 104 OT-1 and
Listeria co-expressing the LCMV gp33 peptide and
N4 Ova (Lm-gp33-N4) or gp33 and T4 Ova
(Lm-gp33-T4). Note that only the gp33 and gp34
epitopes are shared between the consecutive in-
fections. Frequency of blood OT-1 T cells among
total CD8+ T cells was measured 6 days later.
Numbers indicate the OT-1 frequency fold change
between naive and immune hosts.
(C and D) 3 3 105 naive CFSE-labeled OT-1 cells
were transferred at different time points into
ongoing primary Lm-N4 or secondary Lm-WT
and Lm-N4 infections in order to assess
antigen presentation kinetics. CFSE dilution was
measured 80 hr after the transfer.
(E and F) Naive and LCMV-immune mice were in-
fected with 2,000 or 2 3 105 CFU Lm-gp33-T4.
Another LCMV-immune group was co-infected
with 2 3 105 CFU Lm-gp33-T4 plus 2,000 CFU
Lm-WT. Splenic Listeria load was determined
4 days later (E), and the OT-1 frequency among
total blood CD8+ T cells was determined 6 days
later (F).
(G) Naive (–) or LCMV-immune (LCMV) mice
received 104 OT-1 and 106 CFU ActA-deficient
Listeria (ActAgp33-N4 or ActAgp33-T4). The
OT-1 frequency among total blood CD8+ T cells
was determined 6 days later. Numbers indicate the
OT-1 ratio in naive and immune hosts.
The data are representative for two (A–F) or one (G)
independent experiments with n = 3–5 per group.
Statistical analysis are unpaired Student’s t tests
with *p < 0.1, **p < 0.01, ***p < 0.001, and
****p < 0.0001.(Lm-gp33-N4) or the low-affinity APL gp33C6 (Lm-gp33C6-N4).
Again, the memory OT-1 had a minor impact on the P14
response to high-affinity ligands and a much stronger impact
on the lower-affinity gp33C6 response (Figure S3B). These
data also show that aweak or strong response of de novo primed
naive OT-1 or P14 T cells does not impact the response of mem-
ory P14 (Figure S3A) or OT-1 T cells (Figure S3B).
We also examined the phenotype of P14 T cells before (endog-
enous situation) and after the transfer and noticed a larger
population of KLRG1+ T cells among endogenous compared
to transferred memory T cells and a higher proportion of
CD43—CD27— cells (Figures 4C and 4D). Both populations are
thought to have immediate effector function (Olson et al.,
2013). Moreover, Listeria monocytogenes enters the spleen via
the bloodstream and in a dendritic cell dependent fashion (Neu-
enhahn et al., 2006). At this stage, they will likely be in contact
with effector/memory T cells that are positioned in the spleen
in close proximity to the bloodstream. By injecting fluorescently
labeled anti-CD8 antibody into mice, we marked the fraction of
P14 T cells that are in close contact with blood (Galkina et al.,2005). Interestingly, but in line with an earlier publication (Olson
et al., 2013), we saw that the KLRG1+ or CD43—CD27— T cells
(Figure 4E), which show a low engraftment efficacy in our mem-
ory transfers, were enriched among the P14 cells with access to
the blood stream. Therefore, we favor the conclusion that a form
of tissue-resident T cell population is more effective than trans-
ferred T cells in raising the activation threshold in heterosubtypic
infections.
DISCUSSION
We show a clear difference in the TCR stimulation threshold be-
tween primary and secondary infections. Only very high-affinity
ligands activate T cells in immune mice, whereas ligands such
as A2 and Y3, whose EC50 for inducing a half-maximum IFNg
response differed only 2- to 4-fold from the wild-type N4 peptide
(Figure 2A), trigger a much weaker response in immune
compared to naive mice. This is in contrast to the situation in
naive mice in which even ligands with 10,000-fold lower
EC50 activate OT-1 T cells (Figure 2A). Our observations helpCell Reports 17, 627–635, October 11, 2016 631
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Figure 4. Endogenous Memory CD8+ T Cells Effectively Raise the Activation Threshold
(A and B) All mice received 104 OT-1 T cells and some 33 105 (A) or 106 (B) memory P14 T cells. The OT-1 frequency among total CD8+ T cells was determined
7 days after infecting the mice with Lm-gp33-N4 or Lm-gp33-T4. Data are representative for two independent experiments with n = 5 mice per group.
(C–E) CD45.1 P14memory T cells were obtained frommice infected 30–90 days earlier with LCMV and transferred into naive mice. Shown are memory P14 T cell
populations before and after the transfer. Bars represent individual mice, and the relative distribution of the indicated P14 subsets. The plots on the right show the
frequency of KLRG1+ (C) and CD27+CD43+ subpopulations (D). Dots represent individual mice.
(E) Mice with endogenous memory cells were i.v. injected with fluorescently labeled anti-CD8 antibody and sacrificed 3 min. later. CD127/KLRG1 and CD27/
CD43 expression status on antibody-positive and -negative cells are shown as indicated in (D). Data are representative for two to four independent experiments
with n = 3–5 mice per group. Statistical analyses are unpaired Student’s t tests with *p < 0.1, ***p < 0.001, and ****p < 0.0001.to understand T cell responses in heterosubtypic re-infections
caused for instance by different influenza strains or dengue virus
serotypes. Serial infections with the distantly related Lympho-
cytic choriomeningitis virus and Pichinde virus were shown to
induce a narrowed pathogen-specific T cell repertoire because632 Cell Reports 17, 627–635, October 11, 2016of antigens that are shared between these infections (Cornberg
et al., 2006; Welsh et al., 2010). Our data indicate that this exclu-
sion is caused by a memory T-cell-mediated elevation of the
stimulation threshold and that even minimum cross-reactivity is
sufficient to cause this effect.
The exclusion of low-affinity T cells by previously established
memory T cells has consequences for designing vaccine strate-
gies that rely on a prime-boost regimen and intend to elicit a
broad T cell repertoire (such asHIV vaccine trials). Several exam-
ples underline that optimum protection against pathogens is
mediated by highly diverse T cell populations. This ensures
cross-reactivity to pathogens expressing mutated epitopes,
and it enables individuals to better handle a heterosubtypic
infection with a related but non-identical pathogen. It also pre-
vents the selection of escape variants (Price et al., 2004;
Meyer-Olson et al., 2004; Cornberg et al., 2006). T cell receptor
diversity in the population of antigen-specific T cells is largely
facilitated by expanding T cells, which suboptimally respond to
antigen (low-affinity T cells) (Zehn et al., 2009). The focusing of
the T cell repertoire as we observed it may be beneficial for the
ongoing secondary infection, but the narrow repertoire may
severely diminish the ability to subsequently cross-react to
related antigens.
Similarly, tumor immune responses rely on recruiting T cells of
intermediate or low affinity given that high-affinity T cells are
often eliminated by tolerance mechanisms (Enouz et al., 2012).
Our data imply that vaccination strategies, which involve repeti-
tive injections, will perform suboptimally if the vaccine vector
contains previously experienced epitopes. In addition, pre-exist-
ing immunity to vaccine vectors were shown to strongly diminish
the efficacy of inducing T cell immunity. Specifically, adenovirus-
seropositive vaccine recipients had lower HIV-specific re-
sponses to an adenovirus 5-vectored HIV vaccine in comparison
to adenovirus-seronegative recipients (Frahm et al., 2012). In line
with this previous study, our data show that a minimal epitope
overlap is sufficient to impact not only the quantity but also the
breadth of the recruited T cell repertoire. In contrast, memory
T cells do not seem to impact the clonal-like expansion of anti-
gen-specific NK cells (Johnson et al., 2016).
Our data suggest that populations of memory T cells, which
are difficult to transfer, are more effective than transferrable
memory populations in raising the stimulation threshold. These
cells may impair the translocation of antigen-loaded DCs from
the marginal zone into the T cell zone, and this barrier function
may lead to altered antigen presentation and consequently a
higher stimulation threshold. This is in line with a recent report
that highlights the presence of a tissue-resident T cell population
in the spleen (Schenkel et al., 2014). Nonetheless, it remains diffi-
cult to precisely distinguish between qualitative and quantitative
causes for the observed differences between transferred and
endogenousmemory T cells. What supports the notion of a qual-
itative difference is that the transfer of a large number of memory
P14 T cells, which already diminished a high-affinity response,
did not resemble the effect seen with endogenous memory
T cells.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were obtained from Charles River, and OT-1, Rip-mOva, and
CD45.1 congenic C57BL/6 mice were obtained from Jackson Laboratories.
P14 mice were provided by Annette Oxenius (ETH Z€urich). Low-affinity OT-3
TCR transgenic mice were described previously (Enouz et al., 2012). Mice
were bred in specific pathogen-free (SPF) facilities and infected in SPF or con-ventional facilities at the University of Lausanne. Mice that were at least
6 weeks old were used for experiments in compliance with the University of
Lausanne institutional regulations, and the experiments were approved by
the veterinarian authorities of the Swiss Canton Vaud.
Purification, Labeling, and Adoptive Transfer of Cells
Single-cell suspensions were obtained by mashing spleens through a 100 mm
nylon cell strainer (BD Falcon). Red blood cells were lysed with hypotonic
ammonium-chloride-potassium (ACK) lysis buffer. If cells were harvested
less than 5 days after the infection, then the spleens were before mashing di-
gested with 150 mg/mL DNase I (Roche) and 200 mg/mL Liberase TL (Roche)
for 40 min at 37C. The mouse CD8+ T cell enrichment kit (Miltenyi Biotech)
was used for CD8 T cell enrichment. Memory P14 cells were isolated by using
fluorescein isothiocyanate (FITC), phycoerythrin (PE), or biotin-conjugated
CD45.1 antibodies followed by anti-FITC, anti-PE, or anti-biotin MicroBeads
(Miltenyi Biotech) according to the manufacturer’s instructions. Cells were
labeled in serum-free medium with 5 mM CFSE at 37C for 10 min.
Infections
Mice were infected intraperitoneally (i.p.) with 2 3 105 plaque-forming units
(PFU) of Lymphocytic choriomeningitis virus (LCMV strain 53b, Armstrong)
grown and titrated on Vero cells (Utzschneider et al., 2013).Vesicular stomatitis
virus expressing SIINFEKL (N4) (Kim et al., 1998) was grown and titrated on
BHK cells. Mice were infected intravenously ( i.v.) with 2 3 106 PFU. Recom-
binant Listeria monocytogenes strains expressing ovalbumin that contain
Kb/Ova-derived APL were previously described (Zehn et al., 2010). Listeria ex-
pressing the LCMV derived gp33–41 epitope were generated according to
similar protocols. The previously described pPL2 vector (Lauer et al., 2002),
which contains native Ovalbumin (AA134–387) or Ovalbumin with the SIITFEKL
variant (Zehn et al., 2009), were digestedwith SapI. Oligonucleotides encoding
KAVYNFATC (gp33) or KAVYNCATC (gp33C6) plus an alanine on both sides
were ligated into the SapI restriction site. The constructs were inserted into
wild-type or ActA-deficient 10403s Listeria by E. coli conjugation as previously
described (Lauer et al., 2002). Listeria were grown in brain heart infusion broth
(Oxoid, Thermo Fisher) to mid-log phase. Then, bacterial numbers were deter-
mined by measuring the OD at 600 nm, and diluted stocks were i.v. injected in
PBS. Naive mice received 1,000–3,000 colony-forming units (CFU), mice
previously infected with Listeria received 5 3 104 CFU, mice previously in-
fected with LCMV received 2 3105 CFU, and, for infection with ActA-Listeria,
106 CFU were injected. Bacterial loads were determined by lysing spleens in
PBS supplemented with 0.1% Tergitol NP-40 (Sigma-Aldrich). Serial dilutions
were spread out on brain-heart infusion plates containing Streptomycin
(200 mg/mL), and colonies were enumerated.
Identification of the D4-Altered Peptide Ligand
A large pool of SIINFEKL-derived synthetic altered peptide ligands were tested
for H-2Kb stabilization in RMA-S cells and recognition by OT-1 T cells as pre-
viously described (Zehn et al., 2009). The D4 peptide shows similar surface
stabilization as the N4 peptide, but it is a weak agonist for OT-1 T cells
(Figure 2A).
T Cell Expansion and Functional Tests
OT-1 cells were stimulated in RPMI (10%FCS, 100 IU/mL Penicillin, 100 IU/mL
Streptomycin, 5 mM 2-ME, 5 mM HEPES; Invitrogen) with anti-CD3/CD28-
coated beads (Dynabeads, Invitrogen) and cultured with 50 U/mL human
IL-2 (Chiron) in 7% CO2. 6 days after activation, 2 3 10
5 OT-1 cells and
1 3105 RMA cells were mixed in 96-well plates, and titrated concentrations
of SIINFEKL or APL peptides (EMC microcollections) were added. After
30 min, 7 mM Brefeldin A (Sigma-Aldrich) was added, and cultures were incu-
bated for another 3.5 hr.
Surface and Intracellular Staining and Flow Cytometry
Up to 43 106 cells were plated in 96-well plates in PBS supplementedwith 2%
FCS and 0.01% azide. Unspecific antibody binding was blocked with 2.4G2
(BioxCell). Cells were surface stained for 20 min at 4C with fluorescently
labeled anti-CD8 (53–6.7), CD127 (A7R34), KLRG1 (2F1), CD27 (LG7.F9),
CD43 glyco (1B11), CD4 (GK1.5), CD45.1 (A20), and CD45.2 (104) antibodiesCell Reports 17, 627–635, October 11, 2016 633
and fixed in PBS supplemented with 1% formaldehyde, 2% glucose, and
0.03% azide. For intracellular cytokine staining, cells were fixed in PBS 2%
formaldehyde and permeabilized in PBS with 0.25% Saponin and 0.25%
BSA (Perm buffer). Cells were stained in Perm buffer for IFNg (XMG1.2),
TNFa (MP6-XT22), or Granzyme B (GB12). Fluorescently labeled MHC-I-
gp33 multimers were used for detecting gp33-specific T cells (TC-Metrix).
For in vivo staining experiments, we injected mice i.v. with fluorescently
labeled anti-CD8 antibodies. Mice were sacrificed 3 min later, and harvested
organs were processed as indicated above.
Data Analysis and Statistics
Flow cytometry data were obtained on a BD FACS LSRII machine and
analyzed using FlowJo software (Tree Star). GraphPad Prism was used for
graphic representation of data, calculation of EC50 values, and statistical
calculations. Non-paired t tests (two-tailed) were used. p values % 0.05
were considered significant (*p < 0.05; **p < 0.01; ***p < 0.001), and
p values > 0.05 were considered non-significant (ns).
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